• 3102 引文
  • 32 h-指數
20042020

Research output per year

如果您對這些純文本內容做了任何改變,很快就會看到。

研究成果

篩選
Article
2020

A selective Aurora-A 5′-UTR siRNA inhibits tumor growth and metastasis

Lai, C. H., Chen, R. Y., Hsieh, H. P., Tsai, S. J., Chang, K. C., Yen, C. J., Huang, Y. C., Liu, Y. W., Lee, J. C., Lai, Y. C., Hung, L. Y. & Lin, B. W., 2020 三月 1, 於 : Cancer Letters. 472, p. 97-107 11 p.

研究成果: Article

CPAP promotes angiogenesis and metastasis by enhancing STAT3 activity

Chen, R. Y., Yen, C. J., Liu, Y. W., Guo, C. G., Weng, C. Y., Lai, C. H., Wang, J. M., Lin, Y. J. & Hung, L. Y., 2020 四月 1, 於 : Cell Death and Differentiation. 27, 4, p. 1259-1273 15 p.

研究成果: Article

2 引文 斯高帕斯(Scopus)

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS–ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO

Chen, L. T., Martinelli, E., Cheng, A. L., Pentheroudakis, G., Qin, S., Bhattacharyya, G. S., Ikeda, M., Lim, H. Y., Ho, G. F., Choo, S. P., Ren, Z., Malhotra, H., Ueno, M., Ryoo, B. Y., Kiang, T. C., Tai, D., Vogel, A., Cervantes, A., Lu, S. N., Yen, C. J. 及其他9, Huang, Y. H., Chen, S. C., Hsu, C., Shen, Y. C., Tabernero, J., Yen, Y., Hsu, C. H., Yoshino, T. & Douillard, J. Y., 2020 三月, 於 : Annals of Oncology. 31, 3, p. 334-351 18 p.

研究成果: Article

開啟存取
1 引文 斯高帕斯(Scopus)

Satisfaction with pain management and impact of pain on quality of life in cancer patients

Lin, J., Hsieh, R. K., Chen, J. S., Lee, K. D., Rau, K. M., Shao, Y. Y., Sung, Y. C., Yeh, S. P., Chang, C. S., Liu, T. C., Wu, M. F., Lee, M. Y., Yu, M. S., Yen, C. J., Lai, P. Y., Hwang, W. L. & Chiou, T. J., 2020 四月 1, 於 : Asia-Pacific Journal of Clinical Oncology. 16, 2, p. e91-e98

研究成果: Article

1 引文 斯高帕斯(Scopus)
2019

A nationwide survey of adherence to analgesic drugs among cancer patients in Taiwan: prevalence, determinants, and impact on quality of life

Chou, W. C., Chen, J. S., Hung, C. Y., Lu, C. H., Shao, Y. Y., Chiou, T. J., Sung, Y. C., Rau, K. M., Yen, C. J., Yeh, S. P., Liu, T. C., Wu, M. F., Lee, M. Y., Yu, M. S., Hwang, W. L., Lai, P. Y., Chang, C. S. & Hsieh, R. K., 2019 八月 1, 於 : Supportive Care in Cancer. 27, 8, p. 2857-2867 11 p.

研究成果: Article

5 引文 斯高帕斯(Scopus)

A phase 1b study of IMU-131 her2/neu peptide vaccine plus chemotherapy in patients with HER2/neu overexpressing metastatic or advanced adenocarcinoma of the stomach or gastroesophageal junction

Maglakelidze, M., Yau, T., Bulat, I., Yen, C., Chao, Y., Bai, L., Good, A., Ede, N., Chong, L., Tanasanvimon, S., Charoetum, C., Loong, H., Lausoontornsiri, W., Arpornwirat, W., Maneechavakajon, J., Ungtrakul, T. & Chou, W., 2019 七月, 於 : Annals of Oncology. 30, p. iv123

研究成果: Article

A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma

Qin, S., Chan, S. L., Sukeepaisarnjaroen, W., Han, G., Choo, S. P., Sriuranpong, V., Pan, H., Yau, T., Guo, Y., Chen, M., Ren, Z., Xu, J., Yen, C. J., Lin, Z. Z., Manenti, L., Gu, Y., Sun, Y., Tiedt, R., Hao, L., Song, W. 及其他1, Tanwandee, T., 2019 一月 1, 於 : Therapeutic Advances in Medical Oncology. 11

研究成果: Article

開啟存取
1 引文 斯高帕斯(Scopus)

Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma

Lu, L. C., Hsu, C., Shao, Y. Y., Chao, Y., Yen, C. J., Shih, I. L., Hung, Y. P., Chang, C. J., Shen, Y. C., Guo, J. C., Liu, T. H., Hsu, C. H. & Cheng, A. L., 2019 十一月 1, 於 : Liver Cancer. 8, 6, p. 480-490 11 p.

研究成果: Article

開啟存取
1 引文 斯高帕斯(Scopus)

Effect of First-line S-1 Plus Oxaliplatin With or Without Ramucirumab Followed by Paclitaxel Plus Ramucirumab on Advanced Gastric Cancer in East Asia: The Phase 2 RAINSTORM Randomized Clinical Trial

Yoshikawa, T., Muro, K., Shitara, K., Oh, D. Y., Kang, Y. K., Chung, H. C., Kudo, T., Chin, K., Kadowaki, S., Hamamoto, Y., Hironaka, S., Yoshida, K., Yen, C. J., Omuro, Y., Bai, L. Y., Maeda, K., Ozeki, A., Yoshikawa, R. & Kitagawa, Y., 2019 八月 2, 於 : JAMA network open. 2, 8, p. e198243

研究成果: Article

開啟存取
2 引文 斯高帕斯(Scopus)

First-in-human phase i study of fisogatinib (BLU-554) validates aberrant FGF19 signaling as a driver event in hepatocellular carcinoma

Kim, R. D., Sarker, D., Meyer, T., Yau, T., Macarulla, T., Park, J. W., Choo, S. P., Hollebecque, A., Sung, M. W., Lim, H. Y., Mazzaferro, V., Trojan, J., Zhu, A. X., Yoon, J. H., Sharma, S., Lin, Z. Z., Chan, S. L., Faivre, S., Feun, L. G., Yen, C. J. 及其他15, Dufour, J. F., Palmer, D. H., Llovet, J. M., Manoogian, M., Tugnait, M., Stransky, N., Hagel, M., Kohl, N. E., Lengauer, C., Sherwin, C. A., Schmidt-Kittler, O., Hoeflich, K. P., Shi, H., Wolf, B. B. & Kang, Y. K., 2019 十二月, 於 : Cancer Discovery. 9, 12, p. 1696-1707 12 p.

研究成果: Article

開啟存取
9 引文 斯高帕斯(Scopus)

Generation of a heterozygous p53 R249S mutant human embryonic stem cell line by TALEN-mediated genome editing

Huo, Z., Tu, J., Xu, A., Li, Y., Wang, D., Liu, M., Zhou, R., Zhu, D., Lin, Y., Gingold, J. A., Yen, C. J., Xiao, H. & Zhao, R., 2019 一月, 於 : Stem Cell Research. 34, 101360.

研究成果: Article

開啟存取
1 引文 斯高帕斯(Scopus)

Hepatitis B virus X protein (HBx) enhances centrosomal P4.1-associated protein (CPAP) expression to promote hepatocarcinogenesis

Yen, C. J., Yang, S. T., Chen, R. Y., Huang, W., Chayama, K., Lee, M. H., Yang, S. J., Lai, H. S., Yen, H. Y., Hsiao, Y. W., Wang, J. M., Lin, Y. J. & Hung, L. Y., 2019 六月 6, 於 : Journal of biomedical science. 26, 1, 44.

研究成果: Article

開啟存取

Maintenance avelumab versus continuation of first-line chemotherapy in gastric cancer: JAVELIN Gastric 100 study design

Moehler, M., Ryu, M. H., Dvorkin, M., Lee, K. W., Coşkun, H., Wong, R., Chung, H. C., Poltoratsky, A., Tsuji, A., Yen, C. J., Muntean, A. S., Le Sourd, S., Vaccaro, G. M., Overton, L., Boku, N., Wainberg, Z. A., Patel, M., Sharma, M., Xiong, H., Conti, I. 及其他2, Taieb, J. & Bang, Y. J., 2019 二月, 於 : Future Oncology. 15, 6, p. 567-577 11 p.

研究成果: Article

開啟存取
6 引文 斯高帕斯(Scopus)

Multimodal exercise ameliorates exercise responses and body composition in head and neck cancer patients receiving chemotherapy

Yen, C. J., Hung, C. H., Kao, C. L., Tsai, W. M., Chan, S. H., Cheng, H. C., Jheng, W. T., Lu, Y. J. & Tsai, K. L., 2019 十二月 1, 於 : Supportive Care in Cancer. 27, 12, p. 4687-4695 9 p.

研究成果: Article

Oral hygiene and the overall survival of head and neck cancer patients

Chang, C. C., Lee, W. T., Hsiao, J. R., Ou, C. Y., Huang, C. C., Tsai, S. T., Chen, K. C., Huang, J. S., Wong, T. Y., Lai, Y. H., Wu, Y. H., Hsueh, W. T., Wu, S. Y., Yen, C. J., Chang, J. Y., Lin, C. L., Weng, Y. L., Yang, H. C., Chen, Y. S. & Chang, J. S., 2019 四月, 於 : Cancer medicine. 8, 4, p. 1854-1864 11 p.

研究成果: Article

開啟存取
1 引文 斯高帕斯(Scopus)

Patients with head and neck cancer may need more intensive pain management to maintain daily functioning: a multi-center study

Cho, S. F., Rau, K. M., Shao, Y. Y., Yen, C. J., Wu, M. F., Chen, J. S., Chang, C. S., Yeh, S. P., Chiou, T. J., Hsieh, R. K., Lee, M. Y., Sung, Y. C., Lee, K. D., Lai, P. Y., Yu, M. S., Hwang, W. L. & Liu, T. C., 2019 五月 1, 於 : Supportive Care in Cancer. 27, 5, p. 1663-1672 10 p.

研究成果: Article

2 引文 斯高帕斯(Scopus)

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Burtness, B., Harrington, K. J., Greil, R., Soulières, D., Tahara, M., de Castro, G., Psyrri, A., Basté, N., Neupane, P., Bratland, Å., Fuereder, T., Hughes, B. G. M., Mesía, R., Ngamphaiboon, N., Rordorf, T., Wan Ishak, W. Z., Hong, R. L., González Mendoza, R., Roy, A., Zhang, Y. 及其他188, Gumuscu, B., Cheng, J. D., Jin, F., Rischin, D., Lerzo, G., Tatangelo, M., Varela, M., Zarba, J. J., Boyer, M., Gan, H., Gao, B., Hughes, B., Mallesara, G., Taylor, A., Burian, M., Barrios, C. H., de Castro Junior, D. O., Castro, G., Franke, F. A., Girotto, G., Lima, I. P. F., Nicolau, U. R., Pinto, G. D. J., Santos, L., Victorino, A. P., Chua, N., Couture, F., Gregg, R., Hansen, A., Hilton, J., McCarthy, J., Soulieres, D., Ascui, R., Gonzalez, P., Villanueva, L., Torregroza, M., Zambrano, A., Holeckova, P., Kral, Z., Melichar, B., Prausova, J., Vosmik, M., Andersen, M., Gyldenkerne, N., Jurgens, H., Putnik, K., Reinikainen, P., Gruenwald, V., Laban, S., Aravantinos, G., Boukovinas, I., Georgoulias, V., Kwong, D., Al-Farhat, Y., Csoszi, T., Erfan, J., Horvai, G., Landherr, L., Remenar, E., Ruzsa, A., Szota, J., Billan, S., Gluck, I., Gutfeld, O., Popovtzer, A., Benasso, M., Bui, S., Ferrari, V., Licitra, L., Nole, F., Fujii, T., Fujimoto, Y., Hanai, N., Hara, H., Matsumoto, K., Mitsugi, K., Monden, N., Nakayama, M., Okami, K., Oridate, N., Shiga, K., Shimizu, Y., Sugasawa, M., Takahashi, M., Takahashi, S., Tanaka, K., Ueda, T., Yamaguchi, H., Yamazaki, T., Yasumatsu, R., Yokota, T., Yoshizaki, T., Kudaba, I., Stara, Z., Cheah, S. K., Aguilar Ponce, J., Gonzalez Mendoza, R., Hernandez Hernandez, C., Medina Soto, F., Buter, J., Hoeben, A., Oosting, S., Suijkerbuijk, K., Bratland, A., Brydoey, M., Alvarez, R., Mas, L., Caguioa, P., Querol, J., Regala, E. E., Tamayo, M. B., Villegas, E. M., Kawecki, A., Karpenko, A., Klochikhin, A., Smolin, A., Zarubenkov, O., Goh, B. C., Cohen, G., du Toit, J., Jordaan, C., Landers, G., Ruff, P., Szpak, W., Tabane, N., Brana, I., Iglesias Docampo, L., Lavernia, J., Mesia, R., Abel, E., Muratidu, V., Nielsen, N., Cristina, V., Rothschild, S., Wang, H. M., Yang, M. H., Yeh, S. P., Yen, C. J., Soparattanapaisarn, N., Sriuranpong, V., Aksoy, S., Cicin, I., Ekenel, M., Harputluoglu, H., Ozyilkan, O., Harrington, K., Agarwala, S., Ali, H., Alter, R., Anderson, D., Bruce, J., Campbell, N., Conde, M., Deeken, J., Edenfield, W., Feldman, L., Gaughan, E., Goueli, B., Halmos, B., Hegde, U., Hunis, B., Jotte, R., Karnad, A., Khan, S., Laudi, N., Laux, D., Martincic, D., McCune, S., McGaughey, D., Misiukiewicz, K., Mulford, D., Nadler, E., Nunnink, J., Ohr, J., O'Malley, M., Patson, B., Paul, D., Popa, E., Powell, S., Redman, R., Rella, V., Rocha Lima, C., Sivapiragasam, A., Su, Y., Sukari, A., Wong, S., Yilmaz, E. & Yorio, J., 2019 十一月 23, 於 : The Lancet. 394, 10212, p. 1915-1928 14 p.

研究成果: Article

36 引文 斯高帕斯(Scopus)
132 引文 斯高帕斯(Scopus)

Ramucirumab in advanced hepatocellular carcinoma and elevated alpha-fetoprotein following sorafenib: outcomes by prior transarterial chemoembolisation from two randomised, double-blind, placebo-controlled phase 3 studies (REACH-2 and REACH)

Meyer, T., Finn, R., Kudo, M., Kang, Y., Yen, C., Galle, P., Llovet, J., Assenat, E., Brandi, G., Motomura, K., Okusaka, T., Hubner, R., Karwal, M., Baron, A., Ikeda, M., Liang, K., Wang, C., Widau, R., Schelman, W. & Zhu, A., 2019 七月, 於 : Annals of Oncology. 30, p. iv133

研究成果: Article

開啟存取
1 引文 斯高帕斯(Scopus)
1 引文 斯高帕斯(Scopus)
2018

Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: An analysis of the phase 3 REACH study

Chau, I., Park, J. O., Ryoo, B. Y., Yen, C. J., Poon, R., Pastorelli, D., Blanc, J. F., Kudo, M., Pfiffer, T., Hatano, E., Chung, H. C., Kopeckova, K., Phelip, J. M., Brandi, G., Ohkawa, S., Li, C. P., Okusaka, T., Hsu, Y., Abada, P. B. & Zhu, A. X., 2018 七月 3, 於 : British Journal of Cancer. 119, 1, p. 19-26 8 p.

研究成果: Article

7 引文 斯高帕斯(Scopus)

A Phase I/Randomized Phase II Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Nintedanib versus Sorafenib in Asian Patients with Advanced Hepatocellular Carcinoma

Yen, C. J., Kim, T. Y., Feng, Y. H., Chao, Y., Lin, D. Y., Ryoo, B. Y., Huang, D. C. L., Schnell, D., Hocke, J., Loembé, A. B. & Cheng, A. L., 2018 五月 1, 於 : Liver Cancer. 7, 2, p. 165-178 14 p.

研究成果: Article

5 引文 斯高帕斯(Scopus)

Exposure–response relationship of ramucirumab in East Asian patients from RAINBOW: a randomized clinical trial in second-line treatment of gastric cancer

Kim, T. Y., Yen, C. J., Al-Batran, S. E., Ferry, D., Gao, L., Hsu, Y., Cheng, R., Orlando, M. & Ohtsu, A., 2018 三月 1, 於 : Gastric Cancer. 21, 2, p. 276-284 9 p.

研究成果: Article

4 引文 斯高帕斯(Scopus)

Hepatitis B virus surface gene pre-S2 mutant as a high-risk serum marker for hepatoma recurrence after curative hepatic resection

Yen, C., Ai, Y., Tsai, H., Chan, S., Yen, C., Cheng, K., Lee, Y., Kao, C., Wang, Y., Chen, Y., Lin, C., Liu, T., Tsai, H., Wang, J., Su, I. & Huang, W., 2018 九月 1, 於 : Hepatology. 68, 3, p. 815-826

研究成果: Article

Hepatitis B virus surface gene pre-S2 mutant as a high-risk serum marker for hepatoma recurrence after curative hepatic resection

Yen, C. J., Ai, Y. L., Tsai, H. W., Chan, S. H., Yen, C. S., Cheng, K. H., Lee, Y. P., Kao, C. W., Wang, Y. C., Chen, Y. L., Lin, C. H., Liu, T., Tsai, H. P., Wang, J. R., Su, I. J. & Huang, W., 2018 九月, 於 : Hepatology. 68, 3, p. 815-826 12 p.

研究成果: Article

5 引文 斯高帕斯(Scopus)

Hepatocellular carcinoma–related cyclin D1 is selectively regulated by autophagy degradation system

Wu, S. Y., Lan, S. H., Wu, S. R., Chiu, Y. C., Lin, X. Z., Su, I. J., Tsai, T. F., Yen, C. J., Lu, T. H., Liang, F. W., Li, C. Y., Su, H. J., Su, C. L. & Liu, H. S., 2018 七月, 於 : Hepatology. 68, 1, p. 141-154 14 p.

研究成果: Article

20 引文 斯高帕斯(Scopus)

NEK2 promotes hepatoma metastasis and serves as biomarker for high recurrence risk after hepatic resection

Chang, Y. Y., Yen, C. J., Chan, S. H., Chou, Y. W., Lee, Y. P., Bao, C. Y., Huang, C. J. & Huang, W., 2018 九月 1, 於 : Annals of Hepatology. 17, 5, p. 843-856 14 p.

研究成果: Article

4 引文 斯高帕斯(Scopus)

NEK2 Promotes Hepatoma Metastasis and Serves as Biomarker for High Recurrence Risk after Hepatic Resection

Chang, Y., Yen, C., Chan, S., Chou, Y., Lee, Y., Bao, C., Huang, C. & Huang, W., 2018 八月 24, 於 : Annals of Hepatology. 17, 5, p. 843-856

研究成果: Article

198 引文 斯高帕斯(Scopus)

Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma

Abou-Alfa, G. K., Qin, S., Ryoo, B. Y., Lu, S. N., Yen, C. J., Feng, Y. H., Lim, H. Y., Izzo, F., Colombo, M., Sarker, D., Bolondi, L., Vaccaro, G., Harris, W. P., Chen, Z., Hubner, R. A., Meyer, T., Sun, W., Harding, J. J., Hollywood, E. M., Ma, J. 及其他7, Wan, P. J., Ly, M., Bomalaski, J., Johnston, A., Lin, C. C., Chao, Y. & Chen, L. T., 2018 六月 1, 於 : Annals of Oncology. 29, 6, p. 1402-1408 7 p.

研究成果: Article

33 引文 斯高帕斯(Scopus)

Phase II studies with refametinib or refametinib plus sorafenib in patients with RAS-mutated hepatocellular Carcinoma

Lim, H. Y., Merle, P., Weiss, K. H., Yau, T., Ross, P., Mazzaferro, V., Blanc, J. F., Ma, Y. T., Yen, C. J., Kocsis, J., Choo, S. P., Sukeepaisarnjaroen, W., Gerolami, R., Dufour, J. F., Gane, E. J., Ryoo, B. Y., Peck-Radosavljevic, M., Dao, T., Yeo, W., Lamlertthon, W. 及其他7, Thongsawat, S., Teufel, M., Roth, K., Reis, D., Childs, B. H., Krissel, H. & Llovet, J. M., 2018 十月 1, 於 : Clinical Cancer Research. 24, 19, p. 4650-4661 12 p.

研究成果: Article

8 引文 斯高帕斯(Scopus)
4 引文 斯高帕斯(Scopus)

Ramucirumab safety in East Asian patients: A meta-analysis of six global, randomized, double-blind, placebo-controlled, phase III clinical trials

Yen, C. J., Muro, K., Kim, T. W., Kudo, M., Shih, J. Y., Lee, K. W., Chao, Y., Kim, S. W., Yamazaki, K., Sohn, J. H., Cheng, R., Zhang, Y., Binder, P., Mi, G., Orlando, M. & Chung, H. C., 2018 三月 1, 於 : Journal of Global Oncology. 2018, 4

研究成果: Article

開啟存取
3 引文 斯高帕斯(Scopus)
12 引文 斯高帕斯(Scopus)
2017

A phase I/II multicenter study of single-agent foretinib as first-line therapy in patients with advanced hepatocellular carcinoma

Yau, T. C. C., Lencioni, R., Sukeepaisarnjaroen, W., Chao, Y., Yen, C. J., Lausoontornsiri, W., Chen, P. J., Sanpajit, T., Camp, A., Cox, D. S., Gagnon, R. C., Liu, Y., Raffensperger, K. E., Kulkarni, D. A., Kallender, H., Ottesen, L. H., Poon, R. T. P. & Bottaro, D. P., 2017 五月 15, 於 : Clinical Cancer Research. 23, 10, p. 2405-2413 9 p.

研究成果: Article

16 引文 斯高帕斯(Scopus)

A randomized, open-label, Phase III clinical trial of nivolumab vs. therapy of investigator's choice in recurrent squamous cell carcinoma of the head and neck: A subanalysis of Asian patients versus the global population in checkmate 141

Kiyota, N., Hasegawa, Y., Takahashi, S., Yokota, T., Yen, C. J., Iwae, S., Shimizu, Y., Hong, R. L., Goto, M., Kang, J. H., Sum Kenneth Li, W., Ferris, R. L., Gillison, M., Namba, Y., Monga, M., Lynch, M. & Tahara, M., 2017 十月, 於 : Oral Oncology. 73, p. 138-146 9 p.

研究成果: Article

32 引文 斯高帕斯(Scopus)

Cell-free methylation markers with diagnostic and prognostic potential in hepatocellular carcinoma

Lu, C. Y., Chen, S. Y., Peng, H. L., Kan, P. Y., Chang, W. C. & Yen, C. J., 2017 一月 1, 於 : Oncotarget. 8, 4, p. 6406-6418 13 p.

研究成果: Article

10 引文 斯高帕斯(Scopus)

Hepatocellular carcinoma-associated single-nucleotide variants and deletions identified by the use of genome-wide high-throughput analysis of hepatitis B virus

Liu, W. C., Wu, I. C., Lee, Y. C., Lin, C. P., Cheng, J. H., Lin, Y. J., Yen, C. J., Cheng, P. N., Li, P. F., Cheng, Y. T., Cheng, P. W., Sun, K. T., Yan, S. L., Lin, J. J., Yang, J. C., Chang, K. C., Ho, C. H., Tseng, V. S., Chang, B. C. H., Wu, J. C. 及其他1, Chang, T. T., 2017 十月, 於 : Journal of Pathology. 243, 2, p. 176-192 17 p.

研究成果: Article

5 引文 斯高帕斯(Scopus)

Impact of Undertreatment of Cancer Pain With Analgesic Drugs on Patient Outcomes: A Nationwide Survey of Outpatient Cancer Patient Care in Taiwan

Shen, W. C., Chen, J. S., Shao, Y. Y., Lee, K. D., Chiou, T. J., Sung, Y. C., Rau, K. M., Yen, C. J., Liao, Y. M., Liu, T. C., Wu, M. F., Lee, M. Y., Yu, M. S., Hwang, W. L., Lai, P. Y., Chang, C. S., Chou, W. C. & Hsieh, R. K., 2017 七月, 於 : Journal of Pain and Symptom Management. 54, 1, p. 55-65.e1

研究成果: Article

5 引文 斯高帕斯(Scopus)

Inhibition of the EGFR/STAT3/CEBPD Axis reverses cisplatin cross-resistance with paclitaxel in the urothelial carcinoma of the urinary bladder

Wang, W. J., Li, C. F., Chu, Y. Y., Wang, Y. H., Hour, T. C., Yen, C. J., Chang, W. C. & Wang, J. M., 2017 一月 15, 於 : Clinical Cancer Research. 23, 2, p. 503-513 11 p.

研究成果: Article

14 引文 斯高帕斯(Scopus)
12 引文 斯高帕斯(Scopus)

Investigating the association between diet and risk of head and neck cancer in Taiwan

Chang, C. C., Lee, W. T., Lee, Y. C., Huang, C. C., Ou, C. Y., Lin, Y. H., Huang, J. S., Wong, T. Y., Chen, K. C., Hsiao, J. R., Lu, Y. C., Tsai, S. T., Lai, Y. H., Wu, Y. H., Hsueh, W. T., Yen, C. J., Wu, S. Y., Chang, J. Y., Fang, S. Y., Wu, J. L. 及其他5, Lin, C. L., Weng, Y. L., Yang, H. C., Chen, Y. S. & Chang, J. S., 2017 一月 1, 於 : Oncotarget. 8, 58, p. 98865-98875 11 p.

研究成果: Article

5 引文 斯高帕斯(Scopus)

mRECIST to predict survival in advanced hepatocellular carcinoma: Analysis of two randomised phase II trials comparing nintedanib vs sorafenib

Meyer, T., Palmer, D. H., Cheng, A. L., Hocke, J., Loembé, A. B. & Yen, C. J., 2017 七月, 於 : Liver International. 37, 7, p. 1047-1055 9 p.

研究成果: Article

32 引文 斯高帕斯(Scopus)

Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC)

Abou-Alfa, G. K., Yen, C. J., Hsu, C. H., O’Donoghue, J., Beylergil, V., Ruan, S., Pandit-Taskar, N., Gansukh, B., Lyashchenko, S. K., Ma, J., Wan, P., Shao, Y. Y., Lin, Z. Z., Frenette, C., O’Neil, B., Schwartz, L., Smith-Jones, P. M., Ohtomo, T., Tanaka, T., Morikawa, H. 及其他10, Maki, Y., Ohishi, N., Chen, Y. C., Agajanov, T., Boisserie, F., Di Laurenzio, L., Lee, R., Larson, S. M., Cheng, A. L. & Carrasquilo, J. A., 2017 二月 1, 於 : Cancer Chemotherapy and Pharmacology. 79, 2, p. 421-429 9 p.

研究成果: Article

9 引文 斯高帕斯(Scopus)

Preliminary results of a phase 1A/1B study of BGB-A317, an anti-PD-1 monoclonal antibody (mAb), in patients with advanced hepatocellular carcinoma (HCC)

Yen, C. J., Markman, B., Chao, Y., Hill, A., Kang, J., Wang, L., Li, K., Qi, Q., Wu, Z. & Gan, H., 2017 六月, 於 : Annals of Oncology. 28, p. iii54

研究成果: Article

開啟存取
3 引文 斯高帕斯(Scopus)

Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma analysis of REACH trial results by child-pugh score

Zhu, A. X., Baron, A. D., Malfertheiner, P., Kudo, M., Kawazoe, S., Pezet, D., Weissinger, F., Brandi, G., Barone, C. A., Okusaka, T., Wada, Y., Park, J. O., Ryoo, B. Y., Cho, J. Y., Chung, H. C., Li, C. P., Yen, C. J., Lee, K. D., Chang, S. C., Yang, L. 及其他2, Abada, P. B. & Chau, I., 2017 二月, 於 : JAMA Oncology. 3, 2, p. 235-243 9 p.

研究成果: Article

25 引文 斯高帕斯(Scopus)

Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study

Chau, I., Peck-Radosavljevic, M., Borg, C., Malfertheiner, P., Seitz, J. F., Park, J. O., Ryoo, B. Y., Yen, C. J., Kudo, M., Poon, R., Pastorelli, D., Blanc, J. F., Chung, H. C., Baron, A. D., Okusaka, T., Bowman, L., Cui, Z. L., Girvan, A. C., Abada, P. B., Yang, L. 及其他1, Zhu, A. X., 2017 八月, 於 : European Journal of Cancer. 81, p. 17-25 9 p.

研究成果: Article

25 引文 斯高帕斯(Scopus)

Regular recreational physical activity and risk of head and neck cancer

Lin, C. L., Lee, W. T., Ou, C. Y., Hsiao, J. R., Huang, C. C., Huang, J. S., Wong, T. Y., Chen, K. C., Tsai, S. T., Fang, S. Y., Huang, T. T., Wu, J. L., Wu, Y. H., Hsueh, W. T., Yen, C. J., Lai, Y. H., Liao, H. C., Wu, S. Y., Yang, M. W., Lin, F. C. 及其他6, Chang, J. Y., Wang, Y. H., Weng, Y. L., Yang, H. C., Chen, Y. S. & Chang, J. S., 2017 四月 21, 於 : BMC cancer. 17, 1, 286.

研究成果: Article

2016
8 引文 斯高帕斯(Scopus)